Population pharmacokinetics (PK) of oral posaconazole (POS) for antifungal prophylaxis in neutropenic patients with Hematologic malignancies

被引：0
|
作者：
Abu Tarif, Malaz A. [1 ]
Krishna, Gopal [1 ]
Statkevich, Paul [1 ]
机构：
[1] Schering Plough Res Inst, Kenilworth, NJ USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2287.2287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2287
引用
收藏
页码：678A / 678A
页数：1
相关论文
共 50 条
  • [1] Antifungal prophylaxis in neutropenic patients with hematologic malignancies:: Is there a real benefit?
    Böhme, A
    Karthaus, M
    Hoelzer, D
    [J]. CHEMOTHERAPY, 1999, 45 (03) : 224 - 232
  • [2] Impact of testing posaconazole plasma concentrations on epidemiology of antifungal prophylaxis and therapy in patients with hematologic malignancies
    Hoenigl, M.
    Valentin, V.
    Raggam, R. B.
    Valentin, A.
    Woelfler, A.
    Seeber, K.
    Zollner-Schwetz, I.
    Krause, R.
    [J]. MYCOSES, 2012, 55 : 96 - 96
  • [3] ANTIFUNGAL PROPHYLAXIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES - A REAPPRAISAL
    UZUN, O
    ANAISSIE, EJ
    [J]. BLOOD, 1995, 86 (06) : 2063 - 2072
  • [4] Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies
    Hirata, Yuji
    Yokote, Taiji
    Kobayashi, Kichinosuke
    Nakayama, Shoko
    Oka, Satoko
    Miyoshi, Takuji
    Akioka, Toshikazu
    Hiraoka, Nobuya
    Iwaki, Kazuki
    Takayama, Ayami
    Nishimura, Yasuichiro
    Makino, Junko
    Takubo, Takayuki
    Tsuji, Motomu
    Hanafusa, Toshiaki
    [J]. LEUKEMIA & LYMPHOMA, 2010, 51 (05) : 853 - 859
  • [5] Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice
    Bourdelin, Magali
    Grenouillet, Frederic
    Daguindau, Etienne
    Muret, Patrice
    Desbrosses, Yohan
    Dubut, Jonathan
    Deconinck, Eric
    Limat, Samuel
    Larosa, Fabrice
    [J]. MEDICAL MYCOLOGY, 2014, 52 (07) : 728 - 735
  • [6] Antifungal prophylaxis with itraconazole oral solution in neutropenic patients
    Kibbler, CC
    [J]. MYCOSES, 1999, 42 : 121 - 124
  • [7] Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies
    Myoken, Y
    Sugata, T
    Myoken, Y
    Kyo, T
    Fujihara, M
    Mikami, Y
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1999, 87 (02): : 174 - 179
  • [8] Population pharmacokinetics of alemtuzumab in patients with hematologic malignancies
    Bonate, PL
    Keating, M
    Weitman, S
    Hillmen, P
    Mould, DR
    [J]. BLOOD, 2005, 106 (11) : 831A - 831A
  • [9] Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies
    Murali, S.
    Langston, A.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (06) : 480 - 490
  • [10] Antifungal prophylaxis in neutropenic patients
    Boogaerts, MA
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 6 (03) : 149 - 154
12345